United States · FDA National Drug Code directory
LANTIDRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73539-001_a3163e14-0404-4e27-884b-f6f9f7f695bc
- Product NDC
- 73539-001
- Form
- SOLUTION
- Composition / generic term
- DONISLECEL
- Labeler
- CellTrans Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230628
- Source listing expiry
- 20271231
Source-listed ingredients
- DONISLECEL — 5000 [arb'U]/400mL
These values do not establish equivalence or a dose recommendation.
Packages
- 400 mL in 1 BAG (73539-001-01) · 73539-001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →